Cytokinetics Balance Sheet (2010-2026) | CYTK

Balance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
90.56M112.67M115.42M93.63M106.24M67.18M103.22M69.01M100.07M113.40M120.35M190.52M47.26M95.23M74.06M74.94M225.47M122.52M129.84M255.27M
Short-term Investments (Quarter)
387.07M358.97M493.55M492.39M761.43M717.00M562.35M497.08M439.55M501.80M498.99M866.63M964.80M981.16M864.54M783.20M737.07M759.70M688.71M910.41M
Cash & Current Investments (Quarter)
477.64M471.64M608.97M586.03M867.66M784.18M665.56M566.10M539.61M615.20M619.34M1,057.15M1,012.07M1,076.39M938.59M858.13M962.53M882.22M818.55M1,165.69M
Receivables - Net (Quarter)
0.64M51.82M6.06M1.97M2.29M0.15M1.01M0.98M2.50M1.28M0.83M0.24M16.65M2.01M8.41M1.81M17.76M6.83M24.43M
Receivables - Other (Quarter)
Receivables (Quarter)
0.64M51.82M6.06M1.97M2.29M0.15M1.01M0.98M2.50M1.28M0.83M0.24M16.65M2.01M8.41M1.81M17.76M6.83M24.43M
Raw Materials (Quarter)
5.54M
Finished Goods (Quarter)
0.38M
Work In Process (Quarter)
0.99M
Inventory (Quarter)
0.38M
Prepaid Assets (Quarter)
17.99M
Current Assets (Quarter)
1,208.49M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
78.92M
Long-Term Investments (Quarter)
538.32M
Other Non-Current Assets (Quarter)
19.41M
Non-Current Assets (Quarter)
716.06M
Assets (Quarter)
1,924.55M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
20.51M
Notes Payables (Quarter)
30.70M
Payables (Quarter)
51.21M
Accumulated Expenses (Quarter)
76.86M
Other Accumulated Expenses (Quarter)
21.36M
Short term Debt (Quarter)
27.36M
Current Leases (Quarter)
21.04M
Current Deferred Revenue (Quarter)
1.65M
Total Current Liabilities (Quarter)
181.43M
Non-Current Liabilities
Non-Current Debt (Quarter)
248.20M
Convertible Debt (Quarter)
93.89M95.47M134.51M134.67M544.99M545.81M546.51M547.29M548.13M548.99M549.79M550.60M551.48M552.37M553.14M553.99M889.52M
Non-Current Deffered Revenue (Quarter)
87.00M87.00M87.00M87.00M
Operating Leases (Quarter)
102.43M
Other Non-Current Liabilities (Quarter)
30.70M
Total Non-Current Liabilities (Quarter)
2,067.34M
Total Liabilities (Quarter)
2,098.04M
Shareholder's Equity
Total Debt (Quarter)
275.56M
Common Equity (Quarter)
-173.49M
Liabilities and Shareholders Equity (Quarter)
1,924.55M
Retained Earnings (Quarter)
-3900.00M
Treasury Shares (Quarter)
1.41M1.21M1.37M1.87M2.57M